Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study

Background: Pediatric lupus nephritis (LN) is one of the most serious manifestations of systemic lupus erythematosus (SLE) in children, determining the outcomes of the disease. There are no standardized treatment protocols for pediatric LN, and the role of biologics has not yet been conclusively def...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostik, Mikhail, Kalashnikova, Elvira, Rinat, Raupov, Isupova, Eugenia, Gaidar, Ekaterina, Soloviev, Anton A., Masalova, Vera, Snegireva, Ludmila, Kornishina, Tatyana, Abramova, Natalia, Suspitsin, Evgeny, Sorokina, Lubov, Kaneva, Maria, Dubko, Margarita F., Lubimova, Natalia, Kuchuinskaya, Ekaterina, Kalashnikova, Olga, Chasnyk, Vyacheslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216075/
https://www.ncbi.nlm.nih.gov/pubmed/37239173
http://dx.doi.org/10.3390/biomedicines11051503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216075/
https://www.ncbi.nlm.nih.gov/pubmed/37239173
http://dx.doi.org/10.3390/biomedicines11051503

Ejemplares similares